(Presolicitation Notice) Intent to Sole Source - Biol Specimens for Lenacapavir PEP

The CDC plans to award a sole‑source, firm‑fixed‑price purchase order to Emory University for the collection, processing, and delivery of biological specimens from participants taking weekly oral lenacapavir for pre‑exposure prophylaxis (PEP). Emory’s existing HIV clinical‑research infrastructure, prior CDC DHP contract performance, and proximity to the CDC DHP Laboratory in Atlanta make it the preferred source, minimizing technical risk and cold‑chain logistics. The solicitation is a presolicitation notice; quotations may be submitted within 15 days of issuance, but the contract will be negotiated solely with Emory unless the CDC decides otherwise. • Sole‑source award to Emory University for specimen collection and transport. • Specimens derived from persons on weekly oral lenacapavir (HIV PEP). • Requires adherence to CDC DHP laboratory methods and cold‑chain handling. • Proximity to CDC laboratory (Atlanta) reduces shipping time and risk. • Firm‑fixed‑price, no competitive bidding unless CDC elects to open competition.